Ir al contenido
The information contained in this website is intended for International Health Care Professionals. Patients, please refer to your physician for information.
  • About Us
    • Brand History
    • History of P4HB
  • What is GalaFLEX?
    • Instructions for Use
    • What is P4HB?
    • Properties
    • The Scaffold Collection
      • GalaFLEX®
      • GalaFLEX 3D TM
      • GalaFLEX 3DR TM
    • Information for your patient
  • Publications
  • Contact Us
    • Locations
Menú
  • About Us
    • Brand History
    • History of P4HB
  • What is GalaFLEX?
    • Instructions for Use
    • What is P4HB?
    • Properties
    • The Scaffold Collection
      • GalaFLEX®
      • GalaFLEX 3D TM
      • GalaFLEX 3DR TM
    • Information for your patient
  • Publications
  • Contact Us
    • Locations
The information contained in this website is intended for International Health Care Professionals. Patients, please refer to your physician for information.

Publications

What results can be expected one year after complex incisional hernia repair with biosynthetic mesh?

E. Vauclair, M. Bert, O. Facy, N. Cheynel, P. Rat, P. Ortega-Deballon

Journal of Visceral Surgery (2020), JVS-1072 

Background

Incisional hernia is a frequent complication after midline laparotomy. The current standard repair includes the use of a synthetic mesh to prevent recurrence. However, the use of a synthetic mesh in a contaminated field carries a higher risk of mesh infection. In this setting biologic and biosynthetic meshes can be used as they resist to infection, but these are absorbable meshes. This raises the question of the risk of recurrence as the mesh disappears. Phasix® is a biosynthetic mesh getting absorbed in 12—18 months. The aim of this study was to assess the 1-year recurrence rate after abdominal-wall repair with a Phasix® mesh. 

Methods

All patients undergoing ventral hernia repair between 2016 and 2018 at the University Hospital of Dijon using a Phasix® mesh were prospectively included in a database. They were all followed-up with a physical exam and a routine CT scan at one year. All postoperative complications were recorded. 

Results

Twenty-nine patients were included in the study (55.2% women), with a mean BMI of 30,25 kg/m2. Nineteen meshes were sublay and 10 intraperitoneal. Complications at 1 month were mainly mild: Clavien-Dindo I and II (61.1%). No mesh was explanted. There was no chronic infection. The mean length of stay was 11.5 days. The 1-year recurrence rate was 10.3%. Conclusion: Patients having undergone complex ventral hernia repair with a Phasix® mesh have a 1-year recurrence rate of 10.3%. No severe surgical site occurrence was detected. A longer follow-up in a larger number of patients could confirm the place of this mesh in abdominal-wall repair. 

Conclusions

Patients having undergone complex ventral hernia repair with a Phasix® mesh have a 1-year recurrence rate of 10.3%. No severe surgical site occurrence was detected. A longer follow-up in a larger number of patients could confirm the place of this mesh in abdominal-wall repair. 

  • Home
  • About Us
  • What is GalaFLEX?
  • Publications
  • Contact
Menú
  • Home
  • About Us
  • What is GalaFLEX?
  • Publications
  • Contact

See instructions for use here

+ Show References
+ Show patents
Twitter Instagram Linkedin Facebook
Galatea Surgical© 2023. All Rights reserved 500075 Rev B
  • Terms of Use
  • Privacy Policy
Menú
  • Terms of Use
  • Privacy Policy
+ Show References
+ Show patents
Twitter Instagram Linkedin Facebook
Galatea Surgical© 2023. All Rights reserved 500075 Rev DB
  • Terms of Use
  • Privacy Policy
  • Terms of Use
  • Privacy Policy
Important Cookie Information – This message will only appear once. Galatea Surgical website uses cookies. By continuing to browse the site, you are agreeing to the use of cookies.
Read Privacy Policy ACCEPT
Manage consent

Privacy Overview

Read Privacy Policy

Necessary
Siempre activado
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
GUARDAR Y ACEPTAR
The information contained in this website is intended for International Health Care Professionals. Patients, please refer to your physician for information.
  • Home
  • About Us
  • What is GalaFLEX?
  • Publications
  • Contact
  • Home
  • About Us
  • What is GalaFLEX?
  • Publications
  • Contact